| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 841.368 | 862.449 | 851.990 | 803.334 | 749.820 | 666.077 | 662.935 | 780.070 | 815.802 | 922.697 |
| Total Income - EUR | 842.290 | 870.501 | 853.067 | 803.337 | 749.820 | 750.854 | 662.935 | 780.071 | 815.802 | 922.709 |
| Total Expenses - EUR | 792.580 | 769.280 | 757.710 | 736.409 | 704.979 | 679.838 | 627.465 | 753.452 | 779.039 | 855.661 |
| Gross Profit/Loss - EUR | 49.710 | 101.221 | 95.357 | 66.929 | 44.841 | 71.016 | 35.470 | 26.619 | 36.764 | 67.047 |
| Net Profit/Loss - EUR | 40.970 | 84.913 | 71.932 | 58.895 | 38.625 | 65.367 | 30.350 | 20.605 | 25.864 | 50.616 |
| Employees | 8 | 9 | 9 | 8 | 8 | 7 | 7 | 8 | 7 | 8 |
Check the financial reports for the company - Sovirox Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.347 | 9.987 | 8.323 | 41.477 | 31.611 | 22.660 | 19.791 | 10.457 | 7.626 | 6.069 |
| Current Assets | 314.797 | 425.139 | 324.577 | 325.477 | 299.860 | 290.894 | 277.850 | 257.010 | 238.882 | 282.061 |
| Inventories | 146.967 | 128.250 | 128.186 | 133.361 | 126.479 | 58.765 | 74.931 | 87.097 | 88.762 | 105.541 |
| Receivables | 357 | 2.246 | 2.124 | 1.862 | 1.827 | 87.621 | 82.737 | 78.937 | 98.227 | 122.742 |
| Cash | 167.473 | 294.644 | 194.267 | 190.254 | 171.554 | 144.508 | 120.182 | 90.976 | 51.893 | 53.778 |
| Shareholders Funds | 90.339 | 133.779 | 119.971 | 122.941 | 106.502 | 118.166 | 95.359 | 72.393 | 77.495 | 101.959 |
| Social Capital | 49.368 | 48.864 | 48.037 | 47.156 | 46.243 | 45.366 | 44.360 | 44.498 | 44.363 | 44.115 |
| Debts | 246.804 | 301.347 | 212.930 | 244.014 | 224.969 | 195.388 | 202.282 | 195.074 | 169.013 | 186.171 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Sovirox Srl